Addus HomeCare (NASDAQ:ADUS) EVP Sells 6,740 Shares of Company Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Darby Anderson sold 6,740 shares of the company’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $122.72, for a total value of $827,132.80. Following the transaction, the executive vice president directly owned 46,246 shares in the company, valued at $5,675,309.12. This represents a 12.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Addus HomeCare Stock Down 1.4%

Addus HomeCare stock traded down $1.77 during midday trading on Thursday, reaching $123.72. The company’s stock had a trading volume of 135,729 shares, compared to its average volume of 237,235. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.64. The stock has a market capitalization of $2.30 billion, a P/E ratio of 20.62, a PEG ratio of 1.66 and a beta of 0.75. The stock’s 50-day simple moving average is $118.19 and its 200-day simple moving average is $107.10. Addus HomeCare Corporation has a 52-week low of $87.95 and a 52-week high of $131.59.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. The business had revenue of $387.74 million for the quarter, compared to analyst estimates of $388.72 million. During the same quarter in the previous year, the firm earned $1.56 earnings per share. The company’s revenue was up 7.0% on a year-over-year basis. On average, sell-side analysts expect that Addus HomeCare Corporation will post 6.41 EPS for the current year.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. purchased a new stake in Addus HomeCare in the second quarter valued at approximately $344,153,000. Dimensional Fund Advisors LP raised its position in Addus HomeCare by 11.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock worth $69,689,000 after buying an additional 78,415 shares during the last quarter. Bank of America Corp DE purchased a new position in Addus HomeCare during the 2nd quarter worth approximately $35,527,000. TimesSquare Capital Management LLC purchased a new position in Addus HomeCare during the 2nd quarter worth approximately $31,502,000. Finally, Boston Partners lifted its stake in Addus HomeCare by 18.0% during the 3rd quarter. Boston Partners now owns 290,332 shares of the company’s stock valued at $32,222,000 after acquiring an additional 44,279 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on ADUS shares. Raymond James Financial set a $137.00 target price on shares of Addus HomeCare in a research note on Monday, September 28th. TD Cowen upped their price target on shares of Addus HomeCare from $131.00 to $145.00 and gave the company a “buy” rating in a research note on Thursday, November 5th. Truist Financial raised their price target on shares of Addus HomeCare from $135.00 to $148.00 and gave the stock a “buy” rating in a report on Thursday, November 5th. Bank of America downgraded shares of Addus HomeCare from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $140.00 to $125.00 in a research note on Monday, September 14th. Finally, Royal Bank Of Canada lifted their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus target price of $134.70.

Addus HomeCare Company Profile

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.